Kedudukan dalam Saham
#18684
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co.,... Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
Perubahan (1 tahun)
24.67%
Harga 7754 dengan permodalan pasaran b
Modal pasaran bagi AnnJi(7754)
Modal Pasaran: $190.02M
Sehingga August 2026, AnnJi mempunyai modal pasaran sebanyak $190.02M. Ini menjadikan AnnJi syarikat ke-18684th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran AnnJi dari 2024 hingga 2026
7754 berbanding dengan 5 teratas yang paling popular stocks
| Harga 7754 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.088T
|
+2,677,469.31%
|
|
|
|
|
$4.629T
|
+2,436,031.13%
|
|
|
|
|
$4.118T
|
+2,166,847.77%
|
|
|
|
|
$3.687T
|
+1,940,090.74%
|
|
|
|
|
$2.800T
|
+1,473,256.78%
|
